These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36026595)

  • 1. Potential Pitfall of Fluciclovine PET/CT in Castrate-Resistant Prostate Cancer With Adrenal Metastasis.
    Qi J; Nguyen NC
    Clin Nucl Med; 2022 Dec; 47(12):1061-1062. PubMed ID: 36026595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
    Kim EH; Siegel BA; Teoh EJ; Andriole GL;
    Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative 18 F-Piflufolastat PET/CT, But Positive 18 F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer.
    Ulaner GA
    Clin Nucl Med; 2024 Oct; 49(10):968-970. PubMed ID: 38693630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
    Chen B; Wei P; Macapinlac HA; Lu Y
    Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Adenocarcinoma of the Colon on 18 F-Fluciclovine PET/CT.
    Desai C; Clark A; Surasi DS; Flynt L
    Clin Nucl Med; 2024 Jun; 49(6):543-545. PubMed ID: 38598733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
    Chen B; Macapinlac HA; Lu Y
    Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Utility of
    Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
    Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluciclovine-Avid Pulmonary Hamartoma.
    Baldeosingh SC; Rowe SP; Greco SC; Paller CJ; Goel R
    Clin Nucl Med; 2021 Nov; 46(11):919-921. PubMed ID: 34582137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
    Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA;
    J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
    Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
    Chau A; Gardiner P; Colletti PM; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
    Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
    Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of
    Calais J; Fendler WP; Herrmann K; Eiber M; Ceci F
    J Nucl Med; 2018 May; 59(5):789-794. PubMed ID: 29242404
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Calais J; Ceci F; Eiber M; Hope TA; Hofman MS; Rischpler C; Bach-Gansmo T; Nanni C; Savir-Baruch B; Elashoff D; Grogan T; Dahlbom M; Slavik R; Gartmann J; Nguyen K; Lok V; Jadvar H; Kishan AU; Rettig MB; Reiter RE; Fendler WP; Czernin J
    Lancet Oncol; 2019 Sep; 20(9):1286-1294. PubMed ID: 31375469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of [
    Soliman M; Elfatairy K; Ellessy R; Velichko YS; Avery R; Kelahan LC; Ross AE; Savas H
    Br J Radiol; 2023 Dec; 96(1152):20230414. PubMed ID: 37750841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
    Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
    Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using
    Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P
    J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.